Drug substance capability
Upstream manufacturing capability developed around robust process control, quality by design and disciplined technology transfer.
UPSTREAMALTRABIS is developing an integrated industrial platform built around precision, quality and long term security of supply.
A stronger pharmaceutical supply chain starts with controlled capability.
Upstream manufacturing capability developed around robust process control, quality by design and disciplined technology transfer.
UPSTREAMDownstream dosage form and packaging capability designed to translate pharmaceutical substances into dependable finished medicines.
DOWNSTREAMDemand evidence, product selection and execution data connected to support better industrial and commercial decisions.
CONTROL LAYEROne platform.
Complementary capability.
Shared standards.
ALTRABIS is being built around inspection readiness, documented control and lifecycle quality management from the outset.
Quality requirements integrated into process, facility and system decisions.
Traceable information and controlled digital workflows across the operating model.
A phased path towards compliant, auditable and operationally resilient capability.
Our development model reduces execution risk by proving demand, systems and operating readiness before each expansion of industrial capability.
Validate demand, technical fit, supply priorities and the requirements for controlled execution.
Develop people, systems, quality infrastructure and fit for purpose manufacturing capacity.
Scale product, capacity and market reach through institutional capital and controlled partnerships.
We engage with organisations that strengthen industrial execution, quality, capital formation and responsible market access.
For institutional, industrial, technical and commercial conversations, contact the ALTRABIS team.
contact@altrabis.com